February 2012 - Important Notice regarding the BiotechDueDiligence Events Calendar
I've decided to stop maintaining a comprehensive catalyst calendar here on the BiotechDueDiligence site. The information that I have published on this page will continue to be available going forward in a number of different ways:
Comments or Questions? Please email me!
- BioPharm Catalyst - I highly recommend this free site as your starting point for researching important dates in the biotech space. The calendars and database contain PDUFA dates, FDA advisory committee meetings, and other catalysts for a huge number of biotech stocks - far more comprehensive than this page ever was or was intended to be.
- Chimera Research Group Proprietary Database and Calendar - Subscribers gain access to our database of key events and catalysts for companies we cover, compiled and curated by the entire research team. This resource goes beyond the publicly published dates such as PDUFA, Advisory Committees, etc. We include notes from projections and milestones mentioned on all company earnings conference calls, investor and analyst webcasts, scientific meeting/ research and development day webcasts, and personal communication with company executives. As I hope I have demonstrated by example here at BiotechDueDiligence, you simply will not find more comprehensive and up-to-date information on companies within our core coverage universe.
- Chimera Research Group Scientific Meeting Preview Reports - If you know where to look, you can almost always obtain the details of clinical trial and other research presentations at medical conferences before they are announced via company press releases. Recent examples include ASH (December 2011), ASCO GI (January 2012), and ASCO GU (February 2012).
- BiotechDueDiligence and HSP90 Inhibitors blogs - Clinical trial presentations (including some that I do not write about for Chimera Research Group), will also continue to be posted on my blogs, either here on this site, or on my sister site dedicated to the cancer drug class known as heat shock protein 90 (HSP90) inhibitors.
Comments or Questions? Please email me!
Links for archived calendars of events, blog posts, webcast notes, etc by time periodClick here for archive for March - June 2011. Click here for archive for July - September 2011. Click here for archive for October - December 2011. Click here for archive for January - March 2012. Links for archived pipeline slides and much more for the following companies |
|
Other archived content
- Partnership news and updates - many of the small companies covered here at BiotechDueDiligence have one or more partnerships with larger biotech or pharmaceutical companies. It is important to keep tabs on what the partners are saying about these marketed products and development programs. This link is your one-stop shop for all of these updates.
- The biotech Crystal Ball, 2011 edition - my lighthearted predictions for many of the biotech stocks I cover here at BiotechDueDiligence.
- Check near the top of every Stock research page here at BiotechDueDiligence - you will see a list of all blog posts, Chimera Research articles, etc related to that company along with links.
- Catching up on biotech news? Be sure to never fall behind again, sign up for the free BiotechDueDiligence email newsletter that summarizes all of the updates to the site (at most you'll receive one email per week)